NIH-funded research R21 grant

Understanding tooth growth and loss using leopard geckos

Official title: The adult leopard gecko, an emerging, unconventional experimental model for dental research

Funded at University of British Columbia · NIH-10953437 · Data updated 2026-11-12

This study looks at how adult leopard geckos grow and lose their teeth, which might help us understand dental health in people, especially when it comes to how teeth come in and fall out.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of British Columbia
NIH-funded
Lab location1 site (Vancouver, Canada)
Project startSeptember 16, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$295,600
NIH project number1R21DE034155-01
Project IDNIH-10953437 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for benefiting from this research include adults experiencing dental issues related to tooth eruption or premature tooth loss.

Less likely to help

Patients with dental conditions unrelated to tooth eruption or resorption may not benefit from this research.

What this research studies

This research investigates how adult leopard geckos generate and lose teeth, providing insights that could be relevant to human dental health. By studying the unique tooth eruption and resorption processes in geckos, researchers aim to uncover the biological mechanisms that drive these phenomena. The study employs innovative techniques from developmental biology and dental research to explore how teeth move into the mouth and how they are shed. This work could lead to a better understanding of dental issues in humans, particularly those related to tooth eruption and premature loss.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for dental conditions related to tooth eruption and loss in humans.

How similar studies have gone: While the use of leopard geckos as a model for dental research is novel, similar studies in other animal models have shown promise in understanding tooth development and loss.

Where this research is happening

  • University of British Columbia
    Vancouver, Canada
    Active

Researchers

  • Principal investigator: Richman, Joy M. — University of British Columbia
  • Study coordinator: Richman, Joy M.

Related research

Other NIH-funded projects on the same topics.

  • Ethno-epidemiological look at how Vancouver’s overdose Response works

    A Canadian research team studies how evolving drug use and supply changes affect overdose risk and how well current prevention and treatment efforts work for people who use fentanyl and stimulants.

    NIH research University of British Columbia · Vancouver, Canada · NIH-11402718

  • How changing drug supplies affect overdose risk and treatment in Vancouver

    This project looks at how shifts in drugs like fentanyl, stimulants, and novel psychoactive substances change overdose risk and treatment for people who use drugs in Vancouver.

    NIH research University of British Columbia · Vancouver, Canada · NIH-11088722

  • Creating a toolkit to prevent youth overdoses

    This study is creating a helpful toolkit to prevent overdoses in young people aged 12 to 24, giving doctors in pediatric settings the tools they need to provide support and resources like naloxone and education about safe practices.

    NIH research University of British Columbia · Vancouver, Canada · NIH-11055890

  • Understanding how violence affects HIV care for women

    This study looks at how experiences of gender-based violence affect the health and HIV care of cisgender and transgender women living with HIV, especially during the COVID-19 pandemic, and aims to create supportive programs to help these women get the care they need.

    NIH research University of British Columbia · Vancouver, Canada · NIH-10976423

  • Evaluating a program that tests illicit drugs to help prevent overdoses.

    This study is looking at a program in British Columbia that lets people test their drugs for dangerous substances like fentanyl, helping them make safer choices and reduce the risk of overdose.

    NIH research University of British Columbia · Vancouver, Canada · NIH-10676189

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.